RAPT Therapeutics Stock Price

0.15 (0.44%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
RAPT Therapeutics Inc RAPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.15 0.44% 34.37 20:00:00
Open Price Low Price High Price Close Price Prev Close
34.04 33.17 34.83 34.37 34.22
Bid Price Ask Price Spread News
20.00 41.00 21.00 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,594 262,376 $ 34.36 $ 9,016,138 - 14.63 - 43.26
Last Trade Time Type Quantity Stock Price Currency
16:39:15 1 $ 34.00 USD


Draw Mode:

RAPT Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.01B 29.49M 21.29M $ 5.04M $ - -2.19 -14.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.21M 0.90%

more financials information »

RAPT Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RAPT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week39.1040.6733.1737.38450,464-4.73-12.1%
1 Month31.9840.6731.324436.33330,2852.397.47%
3 Months31.6440.6729.0833.59273,5892.738.63%
6 Months22.5443.2617.3235.44574,93211.8352.48%
1 Year27.9043.2614.6330.84441,6066.4723.19%
3 Years12.2551.209510.5229.91291,43622.12180.57%
5 Years12.2551.209510.5229.91291,43622.12180.57%

RAPT Therapeutics Description

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Your Recent History
RAPT Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.